News

24.02.2022 | Petri Lehto, Director of Policy and Communication at MSD Finland Oy & Antti Viitanen, Nordic Head of Government and Public Affairs at Novartis Nordic

An active innovation policy has the potential to bring health sector growth to Finland

This year, the European Commission will announce its proposal for the revision of European pharmaceutical legislation. As a leader in innovation, Finland must ensure that the Commission’s revisions will continue to ensure Europe’s competitiveness in the future.

02.12.2021

Composition of PIF's Board in 2022

Our association elected in the Autumn General Meeting on 29 November 2021 its Board for 2022. The Board will elect the Chairperson and the 1st and 2nd Vice Chairpersons from among the Board Members at its first meeting at the beginning of February.

23.06.2021

Sanna Lauslahti has been elected as a Board member of EFPIA.

Managing Director Sanna Lauslahti has been elected as a Board member of EFPIA.

08.02.2021

Information about vaccines and the COVID-19 situation in Finland

COVID-19 affects us all and like many across Europe, we are still counting the devastating human and economic cost of this pandemic. We share the desire to get safe and effective vaccines to as many people as possible, as quickly as possible.

01.02.2021

The new Chair of the Board of Pharma Industry Finland (PIF), Mr Matthew Iles, wishes to build up closer cooperation

PIF’s new Chair of the Board, Mr Matthew Iles, says that the crises will be solved, the challenges in healthcare will be met and the economic situation in our society will be coped with only by building up good cooperation.

1 2 3 4 5 6 7